Case Study: The immobilization of Carbonic anhydrase
Zymtronix recently demonstrated 101% retained activity of bovine carbonic anhydrase immobilized on its ZymTrap™ platform relative to free counterpart. Read the full... View Article
Zymtronix strengthens its Board of Managers, adding Adam Monroe, a leader in enzyme development and global biotech strategies
27th August 2020 – Ithaca, NY – Zymtronix, developer of revolutionary immobilization and process technologies for enzyme applications, has appointed a new member to its Board of Managers.
Tate & Lyle partners with Zymtronix to leverage novel enzyme immobilization technologies
4 February 2020 – Ithaca, NY and London, UK – Zymtronix, developer of revolutionary enzyme immobilization technologies, and Tate & Lyle PLC (Tate & Lyle), a leading global provider of food and beverage ingredients and solutions, today announced a new partnership.